 Transfusion Reaction
"Transfusion Reaction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
| Descriptor ID |
D065227
|
| MeSH Number(s) |
C15.378.962 C20.920
|
| Concept/Terms |
Transfusion Reaction- Transfusion Reaction
- Transfusion Reactions
- Blood Transfusion-Associated Adverse Reactions
- Blood Transfusion Associated Adverse Reactions
Hemolytic Transfusion Reaction- Hemolytic Transfusion Reaction
- Hemolytic Transfusion Reactions
- Reaction, Hemolytic Transfusion
- Reactions, Hemolytic Transfusion
- Transfusion Reaction, Hemolytic
- Transfusion Reactions, Hemolytic
Transfusion-Transmitted Infection- Transfusion-Transmitted Infection
- Infection, Transfusion-Transmitted
- Transfusion Transmitted Infection
- Transfusion-Transmitted Infections
Transfusion-Associated Circulatory Overload- Transfusion-Associated Circulatory Overload
- Circulatory Overload, Transfusion-Associated
- Circulatory Overloads, Transfusion-Associated
- Transfusion Associated Circulatory Overload
- Transfusion-Associated Circulatory Overloads
Hypotensive Transfusion Reaction- Hypotensive Transfusion Reaction
- Reaction, Hypotensive Transfusion
- Transfusion Reaction, Hypotensive
- Transfusion Reactions, Hypotensive
|
Below are MeSH descriptors whose meaning is more general than "Transfusion Reaction".
Below are MeSH descriptors whose meaning is more specific than "Transfusion Reaction".
This graph shows the total number of publications written about "Transfusion Reaction" by people in this website by year, and whether "Transfusion Reaction" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 1 | 2 | | 1995 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 3 | 0 | 3 | | 2006 | 2 | 1 | 3 | | 2007 | 0 | 2 | 2 | | 2008 | 1 | 1 | 2 | | 2009 | 4 | 2 | 6 | | 2010 | 2 | 0 | 2 | | 2011 | 4 | 1 | 5 | | 2012 | 6 | 1 | 7 | | 2013 | 1 | 0 | 1 | | 2014 | 2 | 1 | 3 | | 2016 | 0 | 2 | 2 | | 2017 | 0 | 2 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2021 | 3 | 0 | 3 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Transfusion Reaction" by people in Profiles.
-
Cancelas JA, Genthe JR, Stolla M, Rugg N, Bailey SL, Nestheide S, Shaz B, Mack S, Schroeder K, Anani W, Szczepiorkowski ZM, Dumont LJ, Yegneswaran S, Corash L, Mufti N, Benjamin RJ, Erickson AC. Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage. Transfusion. 2022 08; 62(8):1619-1629.
-
Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van Helmond N, Golafshar MA, Klassen SA, Klompas AM, Sexton MA, Diaz Soto JC, Grossman BJ, Tobian AAR, Goel R, Wiggins CC, Bruno KA, van Buskirk CM, Stubbs JR, Winters JL, Casadevall A, Paneth NS, Shaz BH, Petersen MM, Sachais BS, Buras MR, Wieczorek MA, Russoniello B, Dumont LJ, Baker SE, Vassallo RR, Shepherd JRA, Young PP, Verdun NC, Marks P, Haley NR, Rea RF, Katz L, Herasevich V, Waxman DA, Whelan ER, Bergman A, Clayburn AJ, Grabowski MK, Larson KF, Ripoll JG, Andersen KJ, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Buchholtz ZA, Pletsch MC, Wright K, Greenshields JT, Joyner MJ, Wright RS, Carter RE, Fairweather D. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS Med. 2021 12; 18(12):e1003872.
-
Lee JS, Khan AD, Wright FL, McIntyre RC, Dorlac WC, Cribari C, Brockman V, Vega SA, Cofran JM, Schroeppel TJ. Whole Blood Versus Conventional Blood Component Massive Transfusion Protocol Therapy in Civilian Trauma Patients. Am Surg. 2022 May; 88(5):880-886.
-
Welsby IJ, Norris PJ, Mauermann WJ, Podgoreanu MV, Conn CM, Meade L, Cannon T, Keating SM, Silliman CC, Kehler M, Schulte PJ, Kor DJ. Bedside Allogeneic Erythrocyte Washing with a Cell Saver to Remove Cytokines, Chemokines, and Cell-derived Microvesicles. Anesthesiology. 2021 03 01; 134(3):395-404.
-
Tai YH, Wu HL, Mandell MS, Lin SP, Tsou MY, Chang KY. The association of non-small cell lung cancer recurrence with allogenic blood transfusion after surgical resection: A propensity score analysis of 1,803 patients. Eur J Cancer. 2020 11; 140:45-54.
-
Vlaar APJ, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, Bolton-Maggs P, Peters AL, Silliman CC, Kor DJ, Kleinman S. An update of the transfusion-related acute lung injury (TRALI) definition. Transfus Clin Biol. 2019 Nov; 26(4):354-356.
-
Castro G, Merkel PA, Giclas HE, Gibula A, Andersen GE, Corash LM, Lin JS, Green J, Knight V, Stassinopoulos A. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease. Transfusion. 2018 06; 58(6):1506-1515.
-
Vostal JG, Buehler PW, Gelderman MP, Alayash AI, Doctor A, Zimring JC, Glynn SA, Hess JR, Klein H, Acker JP, Spinella PC, D'Alessandro A, Palsson B, Raife TJ, Busch MP, McMahon TJ, Intaglietta M, Swartz HM, Dubick MA, Cardin S, Patel RP, Natanson C, Weisel JW, Muszynski JA, Norris PJ, Ness PM. Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016. Transfusion. 2018 01; 58(1):255-266.
-
Vora AN, Stanislawski M, Grunwald GK, Plomondon ME, Rumsfeld JS, Maddox TM, Vidovich MI, Woody W, Nallamothu BK, Gurm HS, Rao SV. Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2017 Apr 18; 6(4).
-
Kelher MR, Banerjee A, Gamboni F, Anderson C, Silliman CC. Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model. Transfusion. 2016 12; 56(12):3004-3011.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|